南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

TRAF4介导的PRMT5泛素化作用可破坏GPX4的稳定性,进而促进动脉粥样硬化患者内皮细胞的铁死亡过程。

TRAF4-mediated PRMT5 ubiquitination destabilizes GPX4 and promotes endothelial ferroptosis in atherosclerosis

Jiayu Wang, Jingjin Li, Jia Zhang, Xin Wei, Yueyang Wu

Journal:CELLULAR SIGNALLING

IF:4.7

DOI:10.1016/j.cellsig.2026.112848

PMID:

Published:2026-08-25

research field:肿瘤学分子生物学免疫学表观遗传学

Abstract

Tumor necrosis factor receptor-associated factor 4 (TRAF4) is a RING-type E3 ubiquitin ligase linked to vascular inflammation, but whether it drives endothelial ferroptosis in atherosclerosis (AS) remains unclear. TRAF4 expression was assessed in GEO dataset GSE166780 , ApoE−/− mice fed a high-fat diet for 4 months, and oxidized low-density lipoprotein (ox-LDL)-treated human coronary artery endothelial cells (HCAECs; 50 μg/mL, 24 h). In vivo, mice received tail-vein delivery of shTRAF4 vector. Plaque burden, endothelial injury, inflammatory responses, and ferroptosis were evaluated by histology, qRT-PCR, western blotting, immunofluorescence, reactive oxygen species (ROS) staining, and biochemical assays. TRAF4-PRMT5 and PRMT5-GPX4 interactions were examined by co-immunoprecipitation and GST pull-down. PRMT5 ubiquitination and protein stability were analyzed using MG132 and cycloheximide assays, and rescue experiments were performed by co-silencing TRAF4 and PRMT5. Our results showed that TRAF4 was upregulated in atherosclerotic tissues, the public dataset, and ox-LDL-treated HCAECs. TRAF4 knockdown reduced plaque burden, VCAM-1 expression, serum lipids and inflammatory cytokines, and attenuated ROS accumulation, ferrous iron (Fe 2+ ) overload, lipid peroxidation, and Glutathione peroxidase 4 (GPX4) loss in vivo. In HCAECs, TRAF4 silencing improved viability, nitric oxide production, and mitochondrial function while reducing apoptosis, monocyte adhesion, inflammatory cytokine release, and ferroptosis. Mechanistically, TRAF4 directly bound PRMT5 and promoted its K48-linked ubiquitin-dependent degradation. CD31/TRAF4 co-staining confirmed endothelial TRAF4 enrichment in atherosclerotic tissue. PRMT5 bound GPX4, enhanced GPX4 methylation, and stabilized GPX4 protein. PRMT5 knockdown partially reversed the anti-ferroptotic effects of TRAF4 deficiency. Overall, TRAF4 promotes endothelial ferroptosis and AS progression by driving PRMT5 ubiquitination and destabilizing GP

本文使用的Yeasen产品

购物车
客服
转染试用